Clinical Trial Update: A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated two doses of Menactra meningococcal conjugate vaccine in healthy toddlers. The trial is completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Meningococcal Meningitis
• Mumps
• Rubella
• Varicella

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Meningitis, Measles | Phase 3 | Status: COMPLETED | Results posted: 2011-06-02